August 9, 2018

Leveraging a Culture of Innovation in Device Development

While innovation may simply be the next buzz word resonating throughout industry, it’s a competitive imperative in medical device.  Yet, identifying the causal inputs that drive sustainable, efficient innovation remain elusive for many firms.  This need not be the case.  Setting the stage for innovation, and developing a culture that supports and nurtures adaptive thinking (solving novel, heretofore unforeseen challenges), are actually grounded in science. Values-Driven Culture Research from the field of positive psychology has […]
June 29, 2018

Notes From the Field – The Drug/Device Combination Product Summit

We recently had the opportunity to speak at the Combination Product Life Cycle Management Summit, which was held in Boston earlier this month. Our co-founder and COO, Phil Burke, presented best practices for developing a dedicated, medical device designed to deliver a therapeutic drug. In attendance were quality, regulatory and device strategy/management professionals from a veritable Who’s Who of Big Pharma. The drug/device combination products market is, in many ways, still relatively nascent. It’s also […]
June 19, 2018

REV•1 Engineering To Speak at Drug/Device Combination Product Summit

Phil Burke to Present “Best Practices” for Device Development with Drug/Device Combination Products at Boston Summit. MURRIETA, Calif. – June 19, 2018 – (FOR IMMEDIATE RELEASE) — REV•1 Engineering will be presenting “Accelerating Along the Critical Path – Identifying Best Practices for De-Risking Device Development for Combination Products” at the Combination Product Life Cycle Management Summit in Boston, MA, June 19th – 21st. Combination products integrate a medical device for the delivery of a therapeutic drug.  Examples can be […]
June 11, 2018

Is Your Innovation Strategy Incremental or Transformational?

I recently had the opportunity to read CB Insights’ 2018 State of Innovation report on the perspectives of nearly 700 senior strategy executives, globally.  As the person in charge of strategic development at a company that specializes in Development and Innovation (D&I), I found the report quite interesting. I’d like to share some of their findings… The survey identified nearly 85% of strategy executives believe innovation is very important to the future performance of their […]
X
Schedule a Conversation
Contact Us